Drug Profile
Research programme: paracetamol prodrugs - NeurogesX
Alternative Names: NGX-1576; NGX-5752; NGX-9674Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator NeurogesX
- Class
- Mechanism of Action Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Pain in USA (PO)
- 03 May 2012 NeurogesX is still seeking business development partners to advance its paracetamol prodrug programme
- 30 May 2011 Preclinical development is ongoing in USA